A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Authors
Keywords
-
Journal
Current Medical Science
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-09
DOI
10.1007/s11596-021-2395-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B cell memory: Understanding COVID-19
- (2021) Isaak Quast et al. IMMUNITY
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
- (2021) Goran Kokic et al. Nature Communications
- COVID-19 evolution during the pandemic – Implications of new SARS-CoV-2 variants on disease control and public health policies
- (2021) Cock van Oosterhout et al. Virulence
- Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
- (2021) Alberto Cagigi et al. Vaccines
- Plitidepsin: a repurposed drug for the treatment of COVID-19
- (2021) Miguel Angel Martinez ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
- (2021) Xiaoying Shen et al. Cell Host & Microbe
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
- (2021) Allison J. Greaney et al. Cell Host & Microbe
- Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
- (2021) Rong Li et al. Cellular & Molecular Immunology
- The Johnson & Johnson Vaccine for COVID-19
- (2021) Edward H. Livingston et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK
- (2021) Oliver T.R. Toovey et al. JOURNAL OF INFECTION
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2021) Zhiwei Wu et al. LANCET INFECTIOUS DISEASES
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report
- (2021) Kai Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
- (2021) Kris M. White et al. SCIENCE
- SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
- (2021) Seiya Ozono et al. Nature Communications
- Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis
- (2021) Meghan O’Hearn et al. Journal of the American Heart Association
- Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
- (2021) Saghi Nooraei et al. JOURNAL OF NANOBIOTECHNOLOGY
- Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
- (2021) Darrell O. Ricke Frontiers in Immunology
- CRISPR Systems for COVID-19 Diagnosis
- (2021) Hossein Rahimi et al. ACS Sensors
- COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
- (2021) Muhammad Umer Ashraf et al. Vaccines
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
- (2021) Alona Kuzmina et al. Cell Host & Microbe
- Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
- (2021) Venkata Viswanadh Edara et al. Cell Host & Microbe
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
- (2021) Linde Schoenmaker et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- COVID-19 mRNA vaccines
- (2021) Qingrui Huang et al. Journal of Genetics and Genomics
- China’s COVID vaccines are going global — but questions remain
- (2021) Smriti Mallapaty NATURE
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA
- (2021) Jasmine Cubuk et al. Nature Communications
- Covid-19: EMA defends AstraZeneca vaccine as Germany and Canada halt rollouts
- (2021) Owen Dyer BMJ-British Medical Journal
- The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
- (2021) Jing Zou et al. npj Vaccines
- Access to and equitable distribution of COVID-19 vaccine in low-income countries
- (2021) Krishna Prasad Acharya et al. npj Vaccines
- SARS-CoV-2 vaccines: a triumph of science and collaboration
- (2021) Jonathan L. Golob et al. JCI Insight
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- (2020) Hong-Yi Zheng et al. Cellular & Molecular Immunology
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Effect of Gastrointestinal Symptoms on Patients Infected With Coronavirus Disease 2019
- (2020) Zili Zhou et al. GASTROENTEROLOGY
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2)
- (2020) Noor Rahman et al. MOLECULES
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2
- (2020) Navpreet Kaur et al. INFECTION GENETICS AND EVOLUTION
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comment on Hu et al: The cytokine storm and COVID‐19
- (2020) Fahad Faqihi et al. JOURNAL OF MEDICAL VIROLOGY
- Critical Differences between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV
- (2020) Chen Bai et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Immune response in COVID-19: A review
- (2020) Mohammad Asaduzzaman Chowdhury et al. Journal of Infection and Public Health
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
- (2020) Shuqin Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- Targeting inflammation and cytokine storm in COVID-19
- (2020) Qianwen Huang et al. PHARMACOLOGICAL RESEARCH
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
- (2020) Sylwester Drożdżal et al. DRUG RESISTANCE UPDATES
- Blood clots in COVID-19 patients: Simplifying the curious mystery
- (2020) Sourav Biswas et al. MEDICAL HYPOTHESES
- Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
- (2020) Robert M. Cox et al. Nature Microbiology
- Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
- (2020) Ma’mon M. Hatmal et al. Cells
- Plant-Based Drugs and Vaccines for COVID-19
- (2020) Nasir Mahmood et al. Vaccines
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
- (2019) Sergio Linares-Fernández et al. TRENDS IN MOLECULAR MEDICINE
- Coronavirus genomic RNA packaging
- (2019) Paul S. Masters VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started